MedPath

sefulness of radiofrequency ablation with infusing the contrast medium into bile duct for hepatocellular carcinoma located near the intrahepatic bile duct

Not Applicable
Recruiting
Conditions
hepatocellular carcinoma
Registration Number
JPRN-UMIN000017701
Lead Sponsor
Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1.Pregnant women and those with possibility of pregnancy. 2.Patients expected liver transplantation within a year. 3.Total serum bilirubin <= 3 mg/dl. 4.Severe ascites. 5.Child-Pugh grade C liver profile. 6.Egg and egg products allergy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of bile duct injury after radiofrequency ablation
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath